In 30 seconds, GP stimulated obese individual to lose weight

23-11-2016 • Aveyard P Lancet 2016
A 30 seconds opportunistic intervention by physicians to motivate weight loss in unselected obese patients led to weight loss when combined with supportive systems. Read more
News • 27-10-2016

New ESC guidelines on atrial fibrillation, in collaboration with EACTS

The ESC, in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), published new guidelines on atrial fibrillation, which are also endorsed by the European Stroke Organisation (ESO). Read more

Physical exertion and anger or emotional upset often precede acute MI

24-10-2016 • Smyth A et al., Circulation 2016
Findings of INTERHEART study support the clinical practice of advising patients to minimise exposure to extremes of anger or emotional upset or vigorous physical exertion. Read more
News • 19-10-2016

AHA Scientific Statement gives guidance on how to limit drug-drug-interactions with statins

Clinically significant drug-drug-interactions with statins and other medications given to treat CVD may be prevented. This document gives recommendations on how to minimise adverse effects. Read more
News • 17-10-2016

AHA panel gives in-depth evaluation of link between hypertension and dementia

The panel considers the evidence insufficient to formulate evidence-based recommendations, but personalised BP management is probably the wisest approach to safeguard cerebrovascular health. Read more

Lower mortality rate with 25 years of intensive lipid-lowering therapy of CAD

10-10-2016 • Zhao XQ et al., J Clin Lipidol 2016
Intensive lipid-lowering therapy for 25 years was associated with significant reductions in CV and total mortality in men with increased LDL-C levels and established coronary artery disease. Read more

Smokers and never-smokers show only modest differences in cardiovascular risk factors

1-11-2016 • Keto J, et al, Open heart, 2016
Differences in lipid profile, blood pressure and CVD risk score between smokers and never-smokers at the age of 46, were too small to result in clinical impact, but there was also hardly difference between former- and never-smokers  Read more
News • 25-10-2016

New ESC/EAS dyslipidaemia guidelines

The updated dyslipidaemia guidelines based on the latest evidence still recommend treatment targets, but lowering lipids beyond the goals may be appropriate in very high risk patients. Read more

No arrhythmias triggered in heart failure patients upon caffeine intake

20-10-2016 • Zuchinali P, et al, JAMA, 2016
The acute ingestion of high doses of caffeine in 51 HF patients did not induce arrhythmias neither at rest, nor during exercise.  Read more

CV morbidity and mortality enhanced with higher pulse pressure

18-10-2016 • McEvoy JW, et al, JACC, 2016
Particularly when DBP was <60 mmHg and SBP above 120 mmHg, patients had higher troponin levels, more frequent CHD events and mortality. Read more

DOACs also beneficial for elderly AF and VTE patients

11-10-2016 • Sadlon AH, Swiss Med Wkly, 2016
Rivaroxaban, apixaban, dabigatran and edoxaban were superior to VKAs in a meta-analysis of 8 studies comprising elderly patients with atrial fibrillation or venous thromboembolism. Read more

Recurrent risk varies substantially in vascular patients: risk stratification can be improved

10-10-2016 • Kaasenbrood L, et al., Circulation 2016
There is substantial variation in the estimated 10-year risk of recurrent vascular events in patients with vascular disease that supports the need for optimisation of risk stratification of these patients. Read more

Upcoming meetings

Meeting reports & resources

EPCCS 2017 Report of the Cardiovascular Summit held in Dublin, Ireland
EPCCS Guidance Documents Evidence- and meeting-based guidance for primary care
EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
All meeting reports...